146 related articles for article (PubMed ID: 31242584)
1. T Regulatory CD4
Dylag-Trojanowska K; Rogala J; Pach R; Siedlar M; Baran J; Sierzega M; Zybaczynska J; Lenart M; Rutkowska-Zapala M; Szczepanik AM
Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31242584
[No Abstract] [Full Text] [Related]
2. [The subpopulation CD4(+); CD25(+); Foxp3(+);/CD127(low/-); regulatory T cells in peripheral blood of HIV-infected patients correlated with disease progression].
Chen YL; Chen XR; Qin LX; Yang YF; Tang YM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Nov; 28(11):1188-91. PubMed ID: 23127412
[TBL] [Abstract][Full Text] [Related]
3. Expression of Th17 and CD4
Xiang M; Guo L; Ma Y; Li Y
Pak J Pharm Sci; 2016 Nov; 29(6 Suppl):2405-2410. PubMed ID: 28167485
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T lymphocytes and transforming growth factor beta in epithelial ovarian tumors-prognostic significance.
Winkler I; Wilczynska B; Bojarska-Junak A; Gogacz M; Adamiak A; Postawski K; Darmochwal-Kolarz D; Rechberger T; Tabarkiewicz J
J Ovarian Res; 2015 Jun; 8():39. PubMed ID: 26077607
[TBL] [Abstract][Full Text] [Related]
5. Circulating T cell subsets are associated with clinical outcome of anti-VEGF-based 1st-line treatment of metastatic colorectal cancer patients: a prospective study with focus on primary tumor sidedness.
Bencsikova B; Budinska E; Selingerova I; Pilatova K; Fedorova L; Greplova K; Nenutil R; Valik D; Obermannova R; Sheard MA; Zdrazilova-Dubska L
BMC Cancer; 2019 Jul; 19(1):687. PubMed ID: 31307428
[TBL] [Abstract][Full Text] [Related]
6. Significance of immunoregulatory T cells in different stages of breast cancer patients.
Abo-Elenein A; Elgohary SE; Hashish A; El-Halaby E
Egypt J Immunol; 2008; 15(2):145-52. PubMed ID: 20306697
[TBL] [Abstract][Full Text] [Related]
7. Absolute of CD4(+)CD25(+)FOXP3(+) regulatory T-cell count rather than its ratio in peripheral blood is related to long-term survival of renal allografts.
Liu L; Deng S; Teng L; Fu Q; Wang C; He X
Transplant Proc; 2012 Jan; 44(1):284-6. PubMed ID: 22310634
[TBL] [Abstract][Full Text] [Related]
8. FoxP3+ regulatory T cells in peripheral blood of patients with epithelial ovarian cancer.
Erfani N; Hamedi-Shahraki M; Rezaeifard S; Haghshenas M; Rasouli M; Samsami Dehaghani A
Iran J Immunol; 2014 Jun; 11(2):105-12. PubMed ID: 24975967
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of frequency of peripheral blood CD4+; CD25(high);Tregs and CD4+; CD25(low);T cells and expression of PD-1 in SLE and RA patients].
Niu Q; Huang ZC; Cai B; Wang LL; Feng WH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jan; 27(1):23-5. PubMed ID: 21208558
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of regulatory T cells proportion in the peripheral blood and tumor tissue in primary hepatocellular carcinoma].
Li SP; Peng QQ; Ding T; Xu J; Zhang CQ; Feng KT; Li JQ
Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):523-7. PubMed ID: 19062720
[TBL] [Abstract][Full Text] [Related]
11. [Circulating regulatory T-cells and changes in the subpopulation composition of lymphocytes in colorectal cancer patients].
Zhulai GA; Oleinik EK; Romanov AA; Oleinik VM; Churov AV; Kravchenko PN
Vopr Onkol; 2016; 62(1):96-100. PubMed ID: 30444585
[TBL] [Abstract][Full Text] [Related]
12. Effects of estrogen on CD4(+) CD25(+) regulatory T cell in peripheral blood during pregnancy.
Xiong YH; Yuan Z; He L
Asian Pac J Trop Med; 2013 Sep; 6(9):748-52. PubMed ID: 23827156
[TBL] [Abstract][Full Text] [Related]
13. [The percentage of regulatory T cells in peripheral blood of chronic lymphocytic leukemia patients and the correlations with clinical prognosis].
Xie P; Pang N; Guo X; Wang L; Zhao F; Wang X; Qu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Dec; 29(12):1307-11. PubMed ID: 24321076
[TBL] [Abstract][Full Text] [Related]
14. [Changes of CD4 + CD25 + Foxp3 + regulatory T cells in the peripheral blood and their correlation with insulin resistance in different stages of prostate cancer].
Zhang BW; Li G; Ye JJ; Li ZR
Zhonghua Nan Ke Xue; 2015 May; 21(5):420-3. PubMed ID: 26117939
[TBL] [Abstract][Full Text] [Related]
15. Expression of Th17 and CD4+ CD25+ T regulatory cells in peripheral blood of acute leukemia patients and their prognostic significance.
Xiang M; Guo L; Ma Y; Li Y
Pak J Pharm Sci; 2017 Mar; 30(2(Suppl.)):619-624. PubMed ID: 28650331
[TBL] [Abstract][Full Text] [Related]
16. Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma.
Shen X; Li N; Li H; Zhang T; Wang F; Li Q
J Cancer Res Clin Oncol; 2010 Nov; 136(11):1745-54. PubMed ID: 20221638
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of CD4
McRae JL; Chia JS; Pommey SA; Dwyer KM
Nephrology (Carlton); 2017 Jul; 22(7):505-512. PubMed ID: 27517975
[TBL] [Abstract][Full Text] [Related]
18. [Study on ratio imbalance of peripheral blood Th17/Treg cells in patients with rheumatoid arthritis].
Niu Q; Huang ZC; Cai B; Wang LL; Feng WH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Mar; 26(3):267-9, 272. PubMed ID: 20230694
[TBL] [Abstract][Full Text] [Related]
19. Analysis of regulatory T cells frequency in peripheral blood and tumor tissues in papillary thyroid carcinoma with and without Hashimoto's thyroiditis.
Liu Y; Yun X; Gao M; Yu Y; Li X
Clin Transl Oncol; 2015 Apr; 17(4):274-80. PubMed ID: 25387566
[TBL] [Abstract][Full Text] [Related]
20. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
